The European Commission has granted marketing authorization to LEO Pharma for Picato gel, for the treatment of actinic keratosis (AK).
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Losing a Malpractice Case May Depend on Where You Live
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
The Role We Play in Addressing Racial Disparity in Dermatology
The Mainstream Patient: February 2
2 Clarke Drive Cranbury, NJ 08512